Cargando…
The evidence on tiotropium bromide in asthma: from the rationale to the bedside
Severe and poorly controlled asthma still accounts for a great portion of the patients affected. Disease control and future risk management have been identified by international guidelines as the main goals in patients with asthma. The need for new treatment approaches has led to reconsider antichol...
Autores principales: | Radovanovic, Dejan, Santus, Pierachille, Blasi, Francesco, Mantero, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420159/ https://www.ncbi.nlm.nih.gov/pubmed/28484598 http://dx.doi.org/10.1186/s40248-017-0094-3 |
Ejemplares similares
-
Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside
por: Radovanovic, Dejan, et al.
Publicado: (2017) -
Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
por: Mantero, Marco, et al.
Publicado: (2018) -
Mucins and Asthma: Are We Headed to the Revolutionary Road?
por: Santus, Pierachille, et al.
Publicado: (2019) -
Tiotropium bromide
por: Lipson, David A
Publicado: (2006) -
Tiotropium Bromide in Chronic Obstructive Pulmonary Disease and Bronchial Asthma
por: Alvarado-Gonzalez, Alcibey, et al.
Publicado: (2015)